MANUEL CASTRO: Open Payments
NPI 1336360874 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 3 payments from 3 companies in 2025. Trend: 2023 $131 · 2024 $140 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 1 | $181 |
| Neurocrine BioSciences, Inc. | 1 | $39 |
| Cumberland Pharmaceuticals, Inc. | 1 | $27 |
Products named: NUPLAZID, INGREZZA, VIBATIV.
Industry payments across NC — which companies pay providers there.
